Abstract
Objectives: To determine the efficacy of lactase enzyme supplement in infant colic. Methods: The double-blind randomised clinical trial was conducted from November 2014 to June 2017 at Kharadar General Hospital, Karachi, and comprised infants aged 0-6 months with infant colic, excessive crying lasting at least 3 hours a day on at least 3 days a week for at least 3 weeks. The subjects were randomised into intervention group A which received lactase enzyme Colibid, and placebo group B. Five drops of intervention preparation were received by all the infants before each feed for two weeks. Confidentiality of active agent and placebo was maintained through drug codes. The duration of crying was recorded at baseline then after first and second weeks of intervention. The two groups were compared with level of significance set at p<0.05. Results: There were 104 subjects with 52(50%) in each of the two groups Overall, 50(48.1%) were boys. At baseline, all (100%) the subjects had infant colic or excessive crying. After two-week intervention, significant improvement was seen in the duration of crying in group A 45(86.5%) compared to group B 31(59.6%) (p<0.05). Conclusion: Significant improvement was seen in the duration of crying in infants who received lactase enzyme supplement.
Original language | English |
---|---|
Pages (from-to) | 1744-1747 |
Number of pages | 4 |
Journal | Journal of the Pakistan Medical Association |
Volume | 68 |
Issue number | 12 |
Publication status | Published - Dec 2018 |
Externally published | Yes |
Keywords
- Colic
- Excessive crying
- Infant
- Lactase
- Lactose intolerance